# Rebecca Todd

> Rebecca Todd is a seed investor at Longwall Venture backing Biotechnology and Health Care. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Longwall Venture](https://shizune.co/investors/profile/longwall-venture-partners)
- Location: Harwell, United Kingdom
- Total investments: 7
- Last investment: Dec 2022
- Lead investor: 43%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/rebeccatodduk/

Rebecca Todd is a seed investor at Longwall Venture in Harwell focused on Biotechnology and Health Care. Rebecca Todd is the investment director of Longwall Venture Partners.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 43% |
| Health Care | 2 | 29% |
| Medical | 1 | 14% |
| Biopharma | 1 | 14% |
| Therapeutics | 1 | 14% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 43% |
| Series A | 1 | 14% |
| Funding Round | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MicrofluidX | MicrofluidX is tackling the problems of process control, scalability, and cost associated with cell bioprocessing, in particular for autologous cell and gene therapy. | $4.3M | Seed | Dec 08, 2022 |  |
| MFX | MFX is a platform designed to accelerate the development and manufacturing of cell and gene therapies. | $4M | Seed | Dec 08, 2022 |  |
| Kinomica | Kinomica is a proteomic-data science and diagnostics company specializing in cell signalling. Kinomica offers KScanTM, a powerful suite of advanced proprietary bioinformatics and phosphoproteomics analytical methods that can provide direct activity measurements of multiple endogenous kinases and comprehensive cell signalling network coverage. | $5.1M | Series A | Dec 14, 2020 |  |
| MicrofluidX | MicrofluidX is tackling the problems of process control, scalability, and cost associated with cell bioprocessing, in particular for autologous cell and gene therapy. | $1.8M | Seed | Apr 21, 2020 |  |
| MFX | MFX is a platform designed to accelerate the development and manufacturing of cell and gene therapies. | $1.7M | Seed | Apr 21, 2020 |  |
| Closed Loop Medicine | Closed Loop Medicine is the global leader in the development of single prescription drug plus digital therapy (DTx) combination products developed to optimise dosing on an individual level with linked behaviour therapy to improve patient outcomes. The company was founded by an experienced team of healthcare professionals, entrepreneurs and lifescientists with experience of both drug and software development, as well as extensive health system innovation experience. The company has two products in development for hypertension and insomnia. It has further products in its pipeline for a wide portfolio of chronic diseases. The Company ensures that both patient and clinician are at the centre of its products design and development. | $2.8M | Seed | May 09, 2019 |  |
| Kinomica | Kinomica is a proteomic-data science and diagnostics company specializing in cell signalling. Kinomica offers KScanTM, a powerful suite of advanced proprietary bioinformatics and phosphoproteomics analytical methods that can provide direct activity measurements of multiple endogenous kinases and comprehensive cell signalling network coverage. |  |  |  |  |

7 of 7 investments shown.

## Co-investors
- [UK Innovation & Science Seed Fund](https://shizune.co/investors/profile/rainbow-seed-fund) — VC Fund, 4 deals together
- [88 Capital](https://shizune.co/investors/profile/88-capital) — VC Fund, 2 deals together
- [Cambridge Angels group](https://shizune.co/investors/profile/cambridge-angels-group) — VC Fund, 2 deals together
- [Moulton Goodies](https://shizune.co/investors/profile/moulton-goodies) — VC Fund, 2 deals together
- [Puffin Point](https://shizune.co/investors/profile/puffin-point) — VC Fund, 2 deals together
- [Alderley Park Ventures](https://shizune.co/investors/profile/alderley-park-ventures) — VC Fund, 1 deal together

## About Longwall Venture

VC Fund · Harwell, United Kingdom

Longwall Ventures LLP is a venture capital firm specializing in growth capital, early stage, and start-up investments. It targets investing in science including physical science, life science, healthcare, security, media, business software, engineering, and technology companies based in United Kingdom. Longwall Ventures LLP was founded in 2011 andis based in Oxford, United Kingdom.

4 contacts available at Longwall Venture.

| Name | Title | Profile |
| --- | --- | --- |
| David Denny | Partner | https://shizune.co/investors/profile/david-denny |
| Matthew Frohn | Partner | https://shizune.co/investors/profile/matthew-frohn |
| Rebecca Todd | Investment Director | https://shizune.co/investors/profile/rebecca-todd |
| Michael Penington | Partner | https://shizune.co/investors/profile/michael-penington |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Rebecca Todd invest in?

Rebecca Todd invests primarily in Biotechnology, Health Care and Medical startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Rebecca Todd last invest?

The most recent investment recorded for Rebecca Todd closed in Dec 2022. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co